REFERENCES
Attanoos RL, Gibbs AR: Pathology of malignant mesothelioma. Histopathology 30:403–418, 1997
Bolen JW, Hammar SP, McNutt MA: Reactive and neoplasticse rosal tissue. Am J Surg Pathol 10:34–47, 1986
Stout AP, Murray MR: Localized pleural mesothelioma: Investigation of its characteristics and histogenesis by the method of tissue culture. Arch Pathol 34:951–964, 1942
Goldstein B: Two malignant pleural mesotheliomas with unusual histological features. Thorax 34:375–379, 1979
Campbell GD, Greenberg SD: Pleural mesothelioma with calcified liver metastases. Chest 79:229–230, 1981
McCaughey WTE: Primary tumors of the pleura. J Pathol Bacteriol 76:517–529, 1958
Persaud V, Bateson EM, Bankay CD: Pleural mesothelioma associated with massive hepatic calcification and unusual me-tastases. Cancer 26:920–928, 1970
Yoshii C, Imai S, Hoshino H, Sugaya H, Mizutani Y, Iwaki H, Enomoto K: A case of malignant pleural mesothelioma with osseous and cartilaginous formation. Jpn J Thorac Dis 30:338–342, 1992
Yousem SA, Hochholzer L: Malignant mesotheliomas with osseous and cartilaginous differentiation. Arch Pathol Lab Med 111:62–66, 1987
Urist MR: Bone: Formation by autoinduction. Science 150:893–899, 1965
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: Molecular clones and activities. Science 242:1528–1534, 1988
Wozney JM: The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32:160–167, 1992
Cunningham NS, Paralkar V, Reddi AH: Osteogenin and recombinant bone morphogene tic protein 2B are chemotactic for human monocyte s and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci USA 89:11740–11744, 1992
Hogan BL: Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 10:1580–1594, 1996
Lind M, Eriksen EF, Bunger C: Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and-6 stimulates che-motactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone 18:53–57, 1996
Paralkar VM, Weeks BS, Yu YM, Kleinman HK, Reddi AH: Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: Potentiation and binding to type IV collagen. J Cell Biol 119:1721–1728, 1992
Ozkaynak E, Schnegelsberg PNJ, Oppermann H: Murine osteogenic protein (OP-1): High levels of mRNA in kidney. Biochem Biophys Res Commun 179:116–123, 1991
Hatakeyama S, Gao YH, Ohara-Nemoto Y, Kataoka H, Satoh M: Expression of bone morphogenetic proteins of human neoplastic epithelial cells. Biochem Mol Biol Int 42:497–505, 1997
Rogers MB, Rosen V, Wozney JM, Gudas LJ: Bone morphogenetic proteins-2 and-4 are involved in there tinoic acidinduced differentiation of embryonal carcinoma cells. Mol Biol Cell 3:189–196, 1992
Hatakeyama S, Ohara-Nemoto Y, Kyakumoto S, Satoh M: Expression of bone morphogene tic protein in human adenocarcinoma cell line. Biochem Biophys Res Commun 190:695–701, 1993
Ogase A, Motoyama T, Hotta T, Watanabe H: Expression of bone morphogenetic proteins in human osteogenic and epithelial tumor cells. Pathol Int 46:9–14, 1996
Dale L, Howes G, Price BMJ, Smith JC: Bone morphogenetic protein 4: A centralizing factor in early Xenopus development. Development 115:573–585, 1992
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159, 1987
Ide H, Yoshida T, Matsumoto N, Aoki K, Osada Y, Sugimura T, Terada M: Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res 57:5022–5027, 1997
Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK, Schnaper HW: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in murine model. Circulation 91:755–762, 1995
Burns TR, Greenberg D, Mace ML, Johnson EH: Ultrastructural diagnosis of epithelial malignant mesothelioma. Cancer 56:2036–2040, 1985
Coleman M, Henderson DW, Muhkerjee TM: The ultrastructural pathology of malignant pleural mesothelioma. Pathol Annu 24:303–353, 1989
Dejmek A: Methods to improve the diagnostic accuracy of malignant mesothelioma. Respir Med 90:191–199, 1996
Holden J, Churg A: Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol 8:277–279, 1984
Sheibani K, Esteban JM, Bailey A, Battifora H, Weiss LM: Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol 23:107–116, 1992
Davis JMG: Histogenesis and fine structure of peritoneal tumors produced in animals by injections of asbestos. J Natl Cancer Inst 52:1823–1837, 1974
Perks WH, Crow JC, Green M: Mesothelioma associated with the syndrome of inappropriate secretion of antidiuretic hormone. Am Rev Respir Dis 117:789–794, 1978
Wozney JM: Bone morphogenetic proteins and their gene expression. In Cellular and Molecular Biology of Bone. M Noda (ed). San Diego, Academic Press, 1993, pp 131–167
Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, Luxenberg DP, McQuaid D, Moutsatsos IK, Nove J, Wozney JM: Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220–2224, 1990
Paralkar VM, Nandedkar AKN, Pointer RH, Battifora H, Weiss LM: Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen. J Biol Chem 28:17281–17284, 1990
Rights and permissions
About this article
Cite this article
Kiyozuka, Y., Miyazaki, H., Yoshizawa, K. et al. Case Report: An Autopsy Case of Malignant Mesothelioma with Osseous and Cartilaginous Differentiation (Bone Morphogenetic Protein-2 in Mesothelial Cells and Its Tumor). Dig Dis Sci 44, 1626–1631 (1999). https://doi.org/10.1023/A:1026627413715
Issue Date:
DOI: https://doi.org/10.1023/A:1026627413715